Login / Signup

Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials.

Luuk J J ScheresWillem M LijferingSaskia MiddeldorpYuk W CheungAlexandru GrigoreanSuzanne C CannegieterMichiel Coppens
Published in: Research and practice in thrombosis and haemostasis (2018)
FVIII:C, FXI:C, FXII:C, and d-dimer measurements were influenced by rivaroxaban/apixaban intake, while fibrinogen and VWF:Ag were not.
Keyphrases
  • venous thromboembolism
  • atrial fibrillation
  • pulmonary embolism
  • weight gain
  • combination therapy
  • body mass index
  • double blind
  • physical activity
  • placebo controlled